Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2
by from Morbidity and Mortality Weekly Report (MMWR) on (#67A4E)
This report describes fewer symptoms and lower rates of hospitalization from mpox among people who had received 1 dose of JYNNEOS vaccine.